Abstract
It has been proposed that C. elegans LIN-9 functions downstream of CDK4 in a pathway that regulates cell proliferation. Here, we report that mammalian BARA/LIN-9 is a predominantly nuclear protein that inhibits cell proliferation. More importantly, we demonstrate that BARA/LIN-9 also acts downstream of cyclin D/CDK4 in mammalian cells since (i) its antiproliferative effect is partially blocked by coexpression of cyclin D1, and (ii) a mutant form that lacks the first 84 amino acids rescues several phenotypic alterations observed in mice null for cdk4. Interestingly, mutation of BARA/LIN-9 restores the expression of E2F target genes in CDK4 null MEFs, indicating that the wild-type protein plays a role in the expression of genes required for the G1/S transition.
Original language | English (US) |
---|---|
Pages (from-to) | 2465-2475 |
Number of pages | 11 |
Journal | Experimental Cell Research |
Volume | 312 |
Issue number | 13 |
DOIs | |
State | Published - Aug 1 2006 |
Funding
We are grateful to Dr. Derrick Rancourt for providing us with the targeting vector. We would like to thank Dr. Phillipp Kaldis for the critical review of this manuscript, Drs. T. Yu and Z. Du for producing the pCMV4-myc-BARA-L and GFP-BARA-L constructs, and D. Salvi for technical assistance. This work has been partially supported by NIH grant GM54709 (ORC) and DK30667 (RDK).
Keywords
- BARA
- CDK
- Cell cycle
- Cyclin
- LIN-9
ASJC Scopus subject areas
- Cell Biology